A new study states that Vitamin D levels act as a key determinant of the human body's response to anti-cancer immunotherapy, especially among people with advanced skin cancer.

The findings, published online in the peer-reviewed journal CANCER, showed that for patients with advanced melanoma, it may be important to maintain normal vitamin D levels when receiving immunotherapy medications called immune checkpoint inhibitors.